Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-08-13
Singh Prahlad R. Files Revvity (RVTY) Form 4 - August 13, 2026
Singh Prahlad R. traded 134.6K RVTY shares in this Form 4 filing, reported to the SEC on 2026-08-13.
- Insider
- Singh Prahlad R.
- Issuer
- Revvity Inc. RVTY · NYSE
- Filed
- Period
- 2026-08-13
- Accession
- 0001193125-26-354025
- Source
- Official filing on sec.gov ↗
Transactions (4)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Singh Prahlad R. | 2026-08-13 | Sell | 7.6K | $0.00 | $0.00 | Direct |
| Singh Prahlad R. | 2026-08-13 | Buy | 7.6K | $0.00 | $0.00 | Indirect |
| Singh Prahlad R. | 2026-08-13 | Sell | 59.6K | $0.00 | $0.00 | Direct |
| Singh Prahlad R. | 2026-08-13 | Buy | 59.6K | $0.00 | $0.00 | Indirect |
| Net change | 0 | $0.00 | ||||
About Revvity Inc.
Revvity Inc. is a prominent company in the healthcare and biological sciences field, offering a comprehensive suite of solutions aimed at improving global health outcomes. The company's core focus lies in delivering innovative products and services that range from diagnostic tools to advanced analytical capabilities for life sciences research. Revvity serves a wide array of sectors including biotechnology, pharmaceuticals, and clinical diagnostics, providing essential tools and data analytics that aid in disease discovery, drug development, and health monitoring. The company's expertise in deploying cutting-edge technologies further reinforces its position as a critical enabler of scientific research and innovation. With its global reach and commitment to enhancing healthcare delivery, Revvity Inc. plays a pivotal role in advancing the capabilities of medical and scientific communities worldwide, driving progress in critical areas such as personalized medicine and preventive healthcare.
Track RVTY insider activity
Get alerted when Revvity Inc. executives buy or sell their shares.